Theofanis Floros

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer.

Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer.

Journal: Translational oncology

Published: May 26, 2025

HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions.

HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions.

Journal: Medicina (Kaunas, Lithuania)

Published: October 31, 2024

Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.

Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.

Journal: JCO precision oncology

Published: January 25, 2024

RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis.

RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis.

Journal: Oncology letters

Published: April 07, 2023

Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients.

Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients.

Journal: Cancer genomics & proteomics

Published: July 12, 2021

Infographic: Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial.

Infographic: Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial.

Journal: The bone & joint journal

Published: March 01, 2021

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.

Journal: BMC cancer

Published: September 03, 2018

A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.

A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.

Journal: Melanoma research

Published: August 22, 2017

Tumor molecular profiling of NSCLC patients using next generation sequencing.

Tumor molecular profiling of NSCLC patients using next generation sequencing.

Journal: Oncology reports

Published: March 30, 2017

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

Journal: Cancer

Published: December 07, 2016

Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.

Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 22, 2016

Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.

Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.

Journal: Seminars in oncology

Published: August 31, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026